Folia Parasitologica 72:021 (2025) | DOI: 10.14411/fp.2025.021

Special Issue: Chronic inflammation in pregnant women with latent toxoplasmosis and explanation of discordant results of serological tests for toxoplasmosis

Jana Ullmann ORCID...1, Jaroslav Flegr ORCID...1, Kamila Nouzová2, Josef Včelák ORCID...3, ©árka Kaňková ORCID...1
1 Department of Philosophy and History of Science, Faculty of Science, Charles University, Prague, Czech Republic;
2 ProfiGyn, s.r.o., Municipal Health Centre Prague, Prague, Czech Republic;
3 Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic

Toxoplasma gondii (Nicolle et Manceaux, 1908), an intracellular parasite that causes toxoplasmosis, infects a third of the human population. Latent toxoplasmosis has been linked to altered immune responses, including elevated proinflammatory cytokines. In early pregnancy, the immune system adapts to balance inflammation and foetal tolerance. This study assessed whether pregnant women in the first trimester infected with Toxoplasma gondii have different cytokine levels than uninfected women. This study also examined whether women with discordant test results for toxoplasmosis represent a distinct group or a mixed group composed of infected women with unusually low levels of anti-Toxoplasma antibodies and uninfected women with high levels of cross-reacting antibodies. We measured 18 cytokines (IL-1β, IL-1ra, IL-2, IL-4, IL-7, IL-9, IL-17A, Eotaxin, FGF basic, G-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α) in 78 pregnant women, classified as Toxoplasma-positive, Toxoplasma-negative or Toxoplasma-discordant (negative by IgG ELISA, positive by complement fixation test [CFT]). Using exploratory factor analysis, we identified two factors, the first explaining 29.6% and the second 24.9% of the total variability in cytokine concentrations. Toxoplasma-positive women scored significantly higher in the second factor, primarily associated with cytokines linked to Th1-driven inflammation and cellular immunity. Specifically, these women exhibited elevated levels of IL-1β, IL-1ra, IL-2, FGF basic and PDGF-BB compared to Toxoplasma-negative women. This finding suggests that pregnant women with latent toxoplasmosis experience some degree of chronic inflammation. Additionally, our results indicate that Toxoplasma-discordant women are likely Toxoplasma-negative individuals with detectable anti-Toxoplasma IgM antibodies. However, as this study focused on pregnant women, further research is necessary to validate these conclusions in broader populations.

Keywords: cytokines, Toxoplasma gondii, pregnancy, immunity

Received: January 23, 2025; Revised: April 22, 2025; Accepted: May 9, 2025; Published online: July 11, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ullmann, J., Flegr, J., Nouzová, K., Včelák, J., & Kaňková, ©. (2025). Special Issue: Chronic inflammation in pregnant women with latent toxoplasmosis and explanation of discordant results of serological tests for toxoplasmosis. Folia Parasitologica72, Article 2025.021. https://doi.org/10.14411/fp.2025.021


This article is part of Special Issue,  Effects of Latent Toxoplasmosis: Three Decades of Studies.


Download citation

References

  1. Althouse A.D. 2016: Adjust for multiple comparisons? It's not that simple. Ann. Thorac. Surg. 101: 1644-1645. Go to original source... Go to PubMed...
  2. Bettelli E., Korn T., Kuchroo V.K. 2007: Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19: 652-657. Go to original source... Go to PubMed...
  3. Curry A.E., Vogel I., Skogstrand K., Drews C., Schendel D.E., Flanders W.D., Hougaard D.M., Thorsen P. 2008: Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors. J. Reprod. Immunol. 77: 152-160. Go to original source... Go to PubMed...
  4. Denkers E.Y., Gazzinelli R.T. 1998: Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11: 569-588. Go to original source... Go to PubMed...
  5. Dimech W., Grangeot-Keros L., Vauloup-Fellous C. 2016: Standardization of assays that detect anti-rubella virus IgG antibodies. Clin. Microbiol. Rev. 29: 163-174. Go to original source... Go to PubMed...
  6. Dlouhá D., Roberts S.C., Hlaváčová J., Nouzová K., Kaňková ©. 2023: Longitudinal changes in disgust sensitivity during pregnancy and the early postpartum period, and the role of recent health problems. Sci. Rep. 13: 4752. Go to original source... Go to PubMed...
  7. Dubey J.P., Lindsay D.S., Speer C.A. 1998: Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11: 267-299. Go to original source... Go to PubMed...
  8. Dunay I.R., Gajurel K., Dhakal R., Liesenfeld O., Montoya J.G. 2018: Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin. Microbiol. Rev. 31: e00057-17. Go to original source... Go to PubMed...
  9. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C., Gilbert R. 1999: Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353: 1829-1833. Go to original source... Go to PubMed...
  10. Dupont C.D., Christian D.A., Hunter C.A. 2012: Immune response and immunopathology during toxoplasmosis. Semin. Immunopathol. 34: 793-813. Go to original source... Go to PubMed...
  11. Eisen H.N. 2014: Affinity enhancement of antibodies: how low-affinity antibodies produced early in immune responses are followed by high-affinity antibodies later and in memory B-cell responses. Cancer Immunol. Res. 2: 381-392. Go to original source... Go to PubMed...
  12. El-Tantawy N., Taman A., Shalaby H. 2014: Toxoplasmosis and female infertility: is there a co-relation? Am. J. Epidemiol. Infect. Dis. 2: 29-32.
  13. Flegr J. 2010: Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitol. 57: 81-87. Go to original source... Go to PubMed...
  14. Flegr J. 2021: Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study. Parasit. Vectors 14: 508. Go to original source... Go to PubMed...
  15. Flegr J., Escudero D.Q. 2016: Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects - an explorative cross-sectional study. Parasitology 143: 1974-1989. Go to original source... Go to PubMed...
  16. Flegr J., Prandota J., Sovičková M., Israili Z.H. 2014: Toxoplasmosis - a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 9: e90203. Go to original source... Go to PubMed...
  17. Flegr J., Stříľ I. 2011: Potential immunomodulatory effects of latent toxoplasmosis in humans. BMC Infect. Dis. 11: 274. Go to original source... Go to PubMed...
  18. Harvanová G., Duranková S., Bernasovská J. 2023: The role of cytokines and chemokines in the inflammatory response. Pol. J. Allergol. 10: 210-219. (In Czech.) Go to original source...
  19. Hostomská L., Jírovec O., Horáčková M., Hrubcová M. 1957: [Relation of toxoplasmosis in mother to mongolism in child]. Česk. Pediatr. 12: 713-723.
  20. Jarmund A.H., Giskeødegård G.F., Ryssdal M., Steinkjer B., Stokkeland L.M.T., Madssen T.S., Stafne S.N., Stridsklev S., Moholdt T., Heimstad R., Vanky E., Iversen A.-C. 2021: Cytokine patterns in maternal serum from first trimester to term and beyond. Front. Immunol. 12: 752660. Go to original source... Go to PubMed...
  21. Kaňková ©., Flegr J. 2007: Longer pregnancy and slower fetal development in women with latent "asymptomatic" toxoplasmosis. BMC Infect. Dis. 7: 114. Go to original source... Go to PubMed...
  22. Kaňková ©., Flegr J., Calda P. 2015: The influence of latent toxoplasmosis on women's reproductive function: four cross-sectional studies. Folia Parasitol. 62: 2015.041. Go to original source... Go to PubMed...
  23. Kaňková ©., Holáň V., Zajícová A., Kodym P., Flegr J. 2010: Modulation of immunity in mice with latent toxoplasmosis - the experimental support for the immunosuppression hypothesis of Toxoplasma-induced changes in reproduction of mice and humans. Parasitol. Res. 107: 1421-1427. Go to original source... Go to PubMed...
  24. Kaňková ©., ©ulc J., Křivohlavá R., Kuběna A., Flegr J. 2012: Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum. Dev. 88: 879-884. Go to original source... Go to PubMed...
  25. Kaňková ©., Takács L., Krulová M., Hlaváčová J., Nouzová K., Hill M., Včelák J., Monk C. 2022: Disgust sensitivity is negatively associated with immune system activity in early pregnancy: direct support for the compensatory prophylaxis hypothesis. Evol. Hum. Behav. 43: 234-241. Go to original source...
  26. Kazemi Arababadi M., Abdollahi S.H., Ramezani M., Zare-Bidaki M. 2024: A review of immunological and neuropsychobehavioral effects of latent toxoplasmosis on humans. Parasite Immunol. 46: e13060. Go to original source... Go to PubMed...
  27. Khan M.M. 2016: Role of cytokines. In: M.M. Khan (Ed.), Immunopharmacology. Springer International Publishing, Cham, pp. 57-92. Go to original source...
  28. Kolbeková P., Kourbatová E., Novotná M., Kodym P., Flegr J. 2007: New and old risk-factors for Toxoplasma gondii infection: prospective cross-sectional study among military personnel in the Czech Republic. Clin. Microbiol. Infect. 13: 1012-1017. Go to original source... Go to PubMed...
  29. Li S., Cui L., Zhao J., Dai P., Zong S., Zuo W., Chen C., Jin H., Gao H., Liu Q. 2011: Seroprevalence of Toxoplasma gondii infection in female sterility patients in China. J. Parasitol. 97: 529-530. Go to original source... Go to PubMed...
  30. Lopez A., Dietz V.J., Wilson M., Navin T.R., Jones J. L. 2000: Preventing congenital toxoplasmosis. MMWR Recomm. Rep. 49: 59-68.
  31. Moghaddami R., Mahdipour M., Ahmadpour E. 2024: Inflammatory pathways of Toxoplasma gondii infection in pregnancy. Travel Med. Infect. Dis. 62: 102760. Go to original source... Go to PubMed...
  32. Mohamed K., Kodym P., Malý M., Intisar E.R. 2012: Assessment of screening tests used to detect Toxoplasma gondii in women in Sudan. J. Med. Diagn. Methods 1: 102. Go to original source...
  33. Montoya J.G. 2002: Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J. Infect. Dis. 185: S73-S82. Go to original source... Go to PubMed...
  34. Neuhäuser M., Krackow S. 2007: Adaptive-filtering of trisomy 21: risk of Down syndrome depends on family size and age of previous child. Naturwissenschaften 94: 117-121. Go to original source... Go to PubMed...
  35. Pernas L., Ramirez R., Holmes T.H., Montoya J.G., Boothroyd J.C. 2014: Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines. J. Infect. Dis. 210: 923-931. Go to original source... Go to PubMed...
  36. Peterson L.S., Stelzer I.A., Tsai A.S., Ghaemi M.S., Han X., Ando K., Winn V.D., Martinez N.R., Contrepois K., Moufarrej M.N., Quake S., Relman D.A., Snyder M.P., Shaw G.M., Stevenson D.K., Wong R.J., Arck P., Angst M.S., Aghaeepour N., Gaudilliere B. 2020: Multiomic immune clockworks of pregnancy. Semin. Immunopathol. 42: 397-412. Go to original source... Go to PubMed...
  37. Prescott S., Mutka T., Baumgartel K., Yoo J.Y., Morgan H., Postolache T.T., Seyfang A., Gostner J.M., Fuchs D., Kim K., Groer M.E. 2023: Tryptophan metabolism and immune alterations in pregnant Hispanic women with chronic Toxoplasma gondii infection. Am. J. Reprod. Immunol. 90: e13768. Go to original source... Go to PubMed...
  38. Racicot K., Kwon J.-Y., Aldo P., Silasi M., Mor G. 2014: Understanding the complexity of the immune system during pregnancy. Am. J. Reprod. Immunol. 72: 107-116. Go to original source... Go to PubMed...
  39. Robert-Gangneux F., Murat J.-B., Fricker-Hidalgo H., Brenier-Pinchart M.-P., Gangneux J.-P., Pelloux H. 2011: The placenta: a main role in congenital toxoplasmosis? Trends Parasitol. 27: 530-536. Go to original source... Go to PubMed...
  40. Sana M., Rashid M., Rashid I., Akbar H., Gomez-Marin J.E., Dimier-Poisson I. 2022: Immune response against toxoplasmosis - some recent updates RH: Toxoplasma gondii immune response. Int. J. Immunopathol. Pharmacol. 36: 1-19. Go to original source... Go to PubMed...
  41. Sharma S., Godbole G., Modi D. 2016: Decidual control of trophoblast invasion. Am. J. Reprod. Immunol. 75: 341-350. Go to original source... Go to PubMed...
  42. Spence T., Allsopp P.J., Yeates A.J., Mulhern M.S., Strain J.J., McSorley E.M. 2021: Maternal serum cytokine concentrations in healthy pregnancy and preeclampsia. J. Pregnancy 2021: 6649608. Go to original source... Go to PubMed...
  43. Tenter A.M., Heckeroth A.R., Weiss L.M. 2000: Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30: 1217-1258. Go to original source... Go to PubMed...
  44. The jamovi project 2022: jamovi. (Version 2.3) [Computer Software]. Retrieved from www.jamovi.org.
  45. Varella I.S., Canti I.C.T., Santos B.R., Coppini A.Z., Argondizzo L.C., Tonin C., Wagner M.B. 2009: Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil. Mem. Inst. Oswaldo Cruz 104: 383-388. Go to original source... Go to PubMed...
  46. Weisel F., Shlomchik M. 2017: Memory B cells of mice and humans. Annu. Rev. Immunol. 35: 255-284. Go to original source... Go to PubMed...
  47. Wolf A., Cowen D., Paige B.H. 1939: Toxoplasmic encephalomyelitis: III. A new case of granulomatous encephalomyelitis due to a protozoon. Am. J. Pathol. 15: 657-694.
  48. Yoon C., Ham Y.S., Gil W.J., Yang C.-S. 2022: The strategies of NLRP3 inflammasome to combat Toxoplasma gondii. Front. Immunol. 13: 1002387. Go to original source... Go to PubMed...